Business Focus
Clinical Focus
Spotlight
100 Years
CME/CE
Job Board
- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
CCE Prostate Cancer: Johns Hopkins by the numbers
The numbers behind Johns Hopkins' Brady Urological Institute
The following data were evaluated to determine Johns Hopkins’ Brady Urological Institute’s standing as a Clinical Center of Excellence for prostate cancer:
1915 – Institute founded
27 – Faculty
24,500 – Number of patients treated/procedures performed in 2008
2,075 – Adult urology inpatientdischarges in 2008
291 – Research protocols in 2008
$5.6 million – Total amount of 11 National Institutes of Health grants allocated to Johns Hopkins in 2007 for urology research
Related Content
